Chardan Healthcare Acquisition Corp. License Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive Patent License Agreement, dated April 22, 2019, among BiomX Ltd., Keio University and JSR Corporation
License Agreements
Chardan Healthcare Acquisition Corp.
Biotechnology
CA
2019
License Modification 1, dated August 31, 2022, to Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research
License Agreements
Chardan Healthcare Acquisition Corp.
2024
Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research, dated August 24, 2021
License Agreements
Chardan Healthcare Acquisition Corp.
2024
First Amendment, dated January 10, 2019, to Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy
License Agreements
Chardan Healthcare Acquisition Corp.
2024
Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy, dated March 16, 2017
License Agreements
Chardan Healthcare Acquisition Corp.
2024
Exclusive Patent License Agreement, dated December 15, 2017, among BiomX Ltd., Keio University and JSR Corporation, as amended
License Agreements
Chardan Healthcare Acquisition Corp.
Biotechnology
CA
2019
Exclusive Patent License Agreement dated April 25, 2017, between BiomX Ltd. and the Massachusetts Institute of Technology
License Agreements
Chardan Healthcare Acquisition Corp.
Biotechnology
NY
2019
Research and License Agreement, dated June 22, 2015, between BiomX Ltd. and Yeda Research and Development Company Limited, as amended
License Agreements
Chardan Healthcare Acquisition Corp.
Biotechnology
2019